Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
NAD refers Generix Labs’ BiphedAdrene ads to FTC; ABCO Labs cited for misbranded and unapproved new drugs; FDA warns RockStar on beverage additives; more Regulatory News In Brief.
You may also be interested in...
Agencies Target “Fraud-Driven” HCG Weight-Loss Ingredient
FDA and FTC warn seven firms that “homeopathic” HCG weight-loss products are unapproved new drugs with unsubstantiated claims. An FTC official says HCG is the latest “fraud driven” weight-loss ingredient.
FDA Supplement Beverage Guidance May Open Can Of Regulatory Worms
An FDA draft guidance has the potential to make defining a beverage as a dietary supplement much tougher
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.